Boston Scientific (BSX): VA awarded $519K
VA awarded Boston Scientific a contract with $519K committed so far.
- $519K
- committed so far
- Signed
- Dec 16, 2025
- Updated
- Dec 16, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 17, 2025CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
- Oct 22, 2025Company filing · Form 8-K · ResultsReported its results
- Oct 22, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 22, 2025, John E. Sununu informed Boston Scientific Corporation (the “Company”) that he will not stand for re-election at the Company’s 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”).”
- Oct 27, 2025InsiderDirector sold ~$1.01M of BSX shares in the open market
- Oct 28, 2025InsiderDirector sold ~$297K of BSX shares in the open market
- Oct 28, 2025CongressDisclosed partial sale of BSX — reported range $15,001 - $50,000
- Oct 30, 2025Congress · 1 personMembers of Congress: 1 purchase, 1 sale
- Oct 31, 2025CongressDisclosed sale of BSX — reported range $1,001 - $15,000
- Nov 3, 2025Insider · 1 personInsiders: 3 sales (~$5.0M)
- Nov 6, 2025InsiderDirector sold ~$1.27M of BSX shares in the open market
- Nov 18, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 18, 2025, upon the recommendation of the Executive Compensation and Human Resources Committee (the “Compensation Committee”), the Board of Directors (the “Board”) of Boston Scientific Corporation (the “Company”) approved the Company’s 2026 Annual Bonus Plan effective for the performance year of January 1, 2026 through December 31, 2026 (the “2026 Annual Bonus Plan”).”
- Nov 18, 2025CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
- Dec 1, 2025InsiderOfficer sold ~$1.76M of BSX shares in the open market
- Dec 16, 2025 · this disclosureFederal contract · $519K obligatedDepartment of Veterans Affairs awarded Boston Scientific: $519K obligated to date
What came next
- Dec 17, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
- Dec 19, 2025FDARecall: HOT AXIOS Stent and Electrocautery-Enhanced Delivery System 6mm x 8mm; Material Number (UPN): M00553520;
- Dec 19, 2025FDARecall: AXIOS Stent and Electrocautery-Enhanced Delivery System - 20mm x 10mm; Material Number (UPN): M00553660;
- Dec 19, 2025FDARecall: *HOT AXIOS Stent and Electrocautery-Enhanced Delivery System 20mm x 10mm; Material Number (UPN): M00553560;
- Dec 19, 2025FDARecall: AXIOS Stent and Electrocautery-Enhanced Delivery System - 6mm x 8mm; Material Number (UPN): M00553680;
- Dec 24, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
- Dec 29, 2025CongressDisclosed purchase of BSX — reported range $15,001 - $50,000
- Jan 14, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
- Jan 23, 2026FDAFDA device clearance: BodyGuardian Remote Monitoring System (BGRMS v3.0)
- Jan 30, 2026CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
- Feb 2, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On February 2, 2026, Yoshiaki Fujimori informed Boston Scientific Corporation (the “Company”) that he will not stand for re-election at the Company’s 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”).”
- Feb 2, 2026Insider · 1 personInsiders: 2 sales (~$15.0M)
- Feb 4, 2026Company filing · Form 8-K · ResultsReported its results
- Feb 10, 2026FDAFDA device clearance: SpaceOAR Vue System (SV-2101)
- Feb 10, 2026FDARecall: EndoVive Safety PEG Kit; Outer Box Material Number (UPN): M00509001; Inner Box Material Number (UPN): M00509000;
- Feb 10, 2026CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
- Feb 12, 2026Federal contract · $519K obligatedDepartment of Veterans Affairs awarded Boston Scientific: $519K obligated to date
- Feb 18, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors (and 1 more item)“On February 18, 2026 the Board of Directors (the “ Board ”) of Boston Scientific Corporation (the “ Company ”), upon the recommendation of the Nominating and Governance Committee of the Board, increased the number of directors comprising the Board from ten to twelve, and appointed each of Catherine R. Smith and Christophe P. Weber to be a director of the Company, to hold office until the next annual meeting of…”
- Feb 26, 2026Company filing · Form 8-K · Material agreement, Agreement endedSigned an important agreement, and ended an important agreement (and 1 more item)
- Mar 5, 2026Court · District Court, D. MassachusettsSecurities lawsuit filed: In re: Boston Scientific Corporation Securities Litigation
How to read USAspending.gov award record
The obligated amount is money the government has legally committed to pay and has set aside in its accounts. The ceiling, which USAspending calls the potential value, is the most the contract could be worth if every option is exercised and every possible order is placed. The ceiling is a limit, not a payment, and it is often many times the obligated amount.
Full guide: Contract ceiling vs obligated amount: the difference
What else is on file for Boston Scientific
For Boston Scientific, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 7 Congress trade reports, 2 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BSX page.
How this filing works
Explore the data
Common questions
What federal contract did Boston Scientific (BSX) receive?
VA awarded Boston Scientific a contract with $519K committed so far.
When did it happen, and when was it made public?
Signed: Dec 16, 2025. Updated: Dec 16, 2025.
Is the contract value money the company has received?
No. The award record gives the amount committed so far and a ceiling the contract may reach. Neither is revenue: the company is paid as the work is delivered, and a contract can be cut short.
Where does this information come from?
From the USAspending.gov award record, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Boston Scientific recently?
For Boston Scientific, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 7 Congress trade reports, 2 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days. They are listed on the BSX page.
Does this mean BSX stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Boston Scientific
- SEC Form 13F-HRNov 16, 2026
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
Everything OQRO holds on this company is on its BSX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
